Anlotinib as a molecular targeted therapy for tumors
Y Gao, P Liu, R Shi - Oncology Letters, 2020 - spandidos-publications.com
… of anlotinib were summarized with a focus on safety evaluation … of anlotinib are summarized
and, more importantly, the safety … use of anlotinib for cancer treatment are fully described. …
and, more importantly, the safety … use of anlotinib for cancer treatment are fully described. …
Efficacy and safety of anlotinib combined with liposomal doxorubicin followed by anlotinib maintenance in metastatic soft tissue sarcomas
Z Liu, W Yao, Y Zhao, O Liu, P Zhang… - Cancer Management and …, 2021 - Taylor & Francis
… Anlotinib is a novel tyrosine kinase inhibitor with promising anti-tumor activity in patients with
… efficacy and safety of anlotinib combined with liposomal doxorubicin followed by anlotinib …
… efficacy and safety of anlotinib combined with liposomal doxorubicin followed by anlotinib …
Clinical investigation of the efficacy and safety of anlotinib with immunotherapy in advanced non-small cell lung cancer as third-line therapy: a retrospective study
S Yang, W Zhang, Q Chen, Q Guo - Cancer Management and …, 2020 - Taylor & Francis
… In this study, we evaluated the efficacy of anlotinib combined with immunotherapy in 101
patients with advanced NSCLC. Our short-term efficacy analysis of these data showed that 19 …
patients with advanced NSCLC. Our short-term efficacy analysis of these data showed that 19 …
Safety and efficacy of chemotherapy combined with anlotinib plus anlotinib maintenance in Chinese patients with advanced/metastatic soft tissue sarcoma
H Wang, J Chu, P Zhang, J Wang, Z Yan… - OncoTargets and …, 2020 - Taylor & Francis
… Anlotinib, a newly developed oral small-molecule receptor tyrosine kinase inhibitor (TKI), …
evaluate the safety and clinical efficacy of chemotherapy combined with anlotinib plus anlotinib …
evaluate the safety and clinical efficacy of chemotherapy combined with anlotinib plus anlotinib …
Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer
L Yu, J Xu, R Qiao, B Han, H Zhong… - Cancer Medicine, 2023 - Wiley Online Library
… We explored the efficacy and safety of combination therapy with anlotinib and programmed
cell death protein 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors as second-line …
cell death protein 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors as second-line …
The efficacy and safety of anlotinib in neoadjuvant treatment of locally advanced thyroid cancer: a single-arm phase II clinical trial
N Huang, W Wei, J Xiang, J Chen, Q Guan, Z Lu, B Ma… - Thyroid, 2021 - liebertpub.com
… We aimed to evaluate the efficacy and safety of anlotinib in … II study investigated the efficacy
and safety of anlotinib (12 mg … aimed to evaluate the efficacy and safety of anlotinib in locally …
and safety of anlotinib (12 mg … aimed to evaluate the efficacy and safety of anlotinib in locally …
Efficacy and safety of anlotinib in patients with unresectable or metastatic bone sarcoma: A retrospective multiple institution study
Z Liu, S Gao, L Zhu, J Wang, P Zhang, P Li… - Cancer …, 2021 - Wiley Online Library
… This retrospective study aims to analyze the safety and efficacy of anlotinib, a novel multi‐target
TKI, in patients with locally unresectable or metastatic bone sarcoma at three institutions. …
TKI, in patients with locally unresectable or metastatic bone sarcoma at three institutions. …
Efficacy and safety of anlotinib for elderly patients with previously treated extensive-stage SCLC and the prognostic significance of common adverse reactions
PF Song, N Xu, Q Li - Cancer Management and Research, 2020 - Taylor & Francis
… regarding the efficacy of … efficacy of patients who were treated with anlotinib was necessary.
Citation21 The aim of the present study was to investigate the efficacy and safety of anlotinib …
Citation21 The aim of the present study was to investigate the efficacy and safety of anlotinib …
Efficacy and safety of anlotinib-containing regimens in advanced non-small cell lung cancer: a real-world study
L Sun, Q Zhao, Y Wang, Y Wang, M Zheng… - … Journal of General …, 2023 - Taylor & Francis
… -world efficacy and safety of anlotinib-containing … , efficacy and safety of anlotinib in real-world
clinical applications, and conducted subgroup analysis to compare the efficacy of anlotinib …
clinical applications, and conducted subgroup analysis to compare the efficacy of anlotinib …
[HTML][HTML] Efficacy and safety of anlotinib as an adjuvant therapy in hepatocellular carcinoma patients with a high risk of postoperative recurrence
J Wang, X Xiang, Z Shi, H Zhang, Q Zhang… - Chinese Journal of …, 2023 - ncbi.nlm.nih.gov
… This study aims to investigate the efficacy and safety of anlotinib in … However, the clinical
application of anlotinib in the … aim to evaluate the efficacy and safety of anlotinib in postoperative …
application of anlotinib in the … aim to evaluate the efficacy and safety of anlotinib in postoperative …